PDB 5hn7
PDB Information
PDB | 5HN7 |
Method | X-RAY DIFFRACTION |
Host Organism | ESCHERICHIA COLI |
Gene Source | Plasmodium vivax |
Primary Citation | Dynamic Structure and Inhibition of a Malaria Drug Target: Geranylgeranyl Diphosphate Synthase.
Biochemistry
|
Header | Transferase/Transferase Inhibitor |
Released | 2016-01-18 |
Resolution | 2.150 |
CATH Insert Date | 09 Oct, 2016 |
PDB Images (17)
PDB Prints
PDB Chains (8)
Chain ID | Date inserted into CATH | CATH Status |
---|---|---|
A | 10 Oct, 2016 | Chopped |
B | 10 Oct, 2016 | Chopped |
C | 10 Oct, 2016 | Chopped |
D | 10 Oct, 2016 | Chopped |
E | 10 Oct, 2016 | Chopped |
F | 10 Oct, 2016 | Chopped |
G | 10 Oct, 2016 | Chopped |
H | 10 Oct, 2016 | Chopped |
CATH Domains (8)
Domain ID | Date inserted into CATH | Superfamily | CATH Status |
---|---|---|---|
5hn7A00 | 13 Oct, 2016 | 1.10.600.10 | Assigned |
5hn7B00 | 15 Oct, 2016 | 1.10.600.10 | Assigned |
5hn7C00 | 15 Oct, 2016 | 1.10.600.10 | Assigned |
5hn7D00 | 15 Oct, 2016 | 1.10.600.10 | Assigned |
5hn7E00 | 15 Oct, 2016 | 1.10.600.10 | Assigned |
5hn7F00 | 15 Oct, 2016 | 1.10.600.10 | Assigned |
5hn7G00 | 14 Oct, 2016 | 1.10.600.10 | Assigned |
5hn7H00 | 15 Oct, 2016 | 1.10.600.10 | Assigned |
UniProtKB Entries (8)
Accession | Gene ID | Taxon | Description |
---|---|---|---|
A5K4U6 | A5K4U6_PLAVS | Plasmodium vivax Sal-1 | Farnesyl pyrophosphate synthase, putative |
A5K4U6 | A5K4U6_PLAVS | Plasmodium vivax Sal-1 | Farnesyl pyrophosphate synthase, putative |
A5K4U6 | A5K4U6_PLAVS | Plasmodium vivax Sal-1 | Farnesyl pyrophosphate synthase, putative |
A5K4U6 | A5K4U6_PLAVS | Plasmodium vivax Sal-1 | Farnesyl pyrophosphate synthase, putative |
A5K4U6 | A5K4U6_PLAVS | Plasmodium vivax Sal-1 | Farnesyl pyrophosphate synthase, putative |
A5K4U6 | A5K4U6_PLAVS | Plasmodium vivax Sal-1 | Farnesyl pyrophosphate synthase, putative |
A5K4U6 | A5K4U6_PLAVS | Plasmodium vivax Sal-1 | Farnesyl pyrophosphate synthase, putative |
A5K4U6 | A5K4U6_PLAVS | Plasmodium vivax Sal-1 | Farnesyl pyrophosphate synthase, putative |